Skip to main content

Caliper's Shares Drop Despite Patent Allowance

Shares in Caliper Life Sciences fell nearly 10 percent for the five-day trading period ended Tuesday, despite the firm’s announcement last week that it had received a key patent allowance (see related article). The firm also reaffirmed its full-year revenue guidance of $137 million to $143 million.
 
Sequenom led gainers for the week with a rise of 14.9 percent. The firm announced a deal last week to provide gene-expression services for the Immune Tolerance Network. Illumina also had a strong week with its shares gaining 8.8 percent.
 
Overall, the BCW Index rose .4 percent for the week. In comparison, the Dow Jones Industrial Average rose .5 percent, the Nasdaq gained 1.5 percent, and the Nasdaq Biotech Index closed up .8 percent for the tracking period.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(June 5, 2007)
Starting Price
(
May 29, 2007)
% change
Affymetrix
AFFX
26.17
26.26
-0.34
Agilent
A
38.47
38.32
0.39
Applied Biosystems
ABI
28.92
28.57
1.23
Beckman
BEC
66.26
65.89
0.56
Becton Dickinson
BDX
75.54
76.58
-1.36
Bio-Rad
BIO
74.13
74.47
-0.46
Bruker
BRKR
8.71
8.51
2.35
Caliper
CALP
4.25
4.7
-9.57
Cepheid
CPHD
11.87
11.67
1.71
Illumina
ILMN
35.51
32.63
8.83
Invitrogen
IVGN
73.64
71.82
2.53
Luminex
LMNX
12.20
12.81
-4.76
MDS
MDZ
20.51
20.07
2.19
Millipore
MIL
74.77
74.68
0.12
PerkinElmer
PKI
26.68
26.1
2.22
Qiagen
QGEN
16.57
17.21
-3.72
Sequenom
SQNM
4.79
4.17
14.87
Sigma-Aldrich
SIAL
43.01
43.02
-0.02
Stratagene
STGN
10.93
10.85
0.74
Thermo
TMO
53.17
54.06
-1.65
Third Wave
TWTI
6.13
5.96
2.85
Waters
WAT
59.61
60.57
-1.58
BCW Index Average  
35.08
34.95
0.38
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.